참고문헌
- Bahri, S., Wang, S., Conder, R., Choy, J., Vlachos, S., Dong, K., Merino, C., Sigrist, S., Molnar, C., Yang, X., et al. (2010). The leading edge during dorsal closure as a model for epithelial plasticity: Pak is required for recruitment of the Scribble complex and septate junction formation. Development 137, 2023-2032. https://doi.org/10.1242/dev.045088
- Ben Halima, S., Siegel, G., and Rajendran, L. (2016). miR-186 in Alzheimer's disease: a big hope for a small RNA? J. Neurochem. 137, 308-311. https://doi.org/10.1111/jnc.13573
- Chou, J., Wang, B., Zheng, T., Li, X., Zheng, L., Hu, J., Zhang, Y., Xing, Y., and Xi, T. (2016). MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42. Biochem. Biophys. Res. Commun. 472, 262-269. https://doi.org/10.1016/j.bbrc.2016.02.102
- de Marinis, F., and Grossi, F. (2008). Clinical evidence for secondand third-line treatment options in advanced non-small cell lung cancer. Oncologist 13 Suppl 1, 14-20.
- Etienne-Manneville, S. (2004). Cdc42--the centre of polarity. J. Cell Sci. 117, 1291-1300. https://doi.org/10.1242/jcs.01115
- Hornberger, J., Hirsch, F.R., Li, Q., and Page, R.D. (2015). Outcome and economic implications of proteomic test-guided second- or thirdline treatment for advanced non-small cell lung cancer: extended analysis of the PROSE trial. Lung Cancer 88, 223-230. https://doi.org/10.1016/j.lungcan.2015.03.006
- Jemal, A., Center, M.M., DeSantis, C., and Ward, E.M. (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 19, 1893-1907. https://doi.org/10.1158/1055-9965.EPI-10-0437
- Ji, W., Sun, B., and Su, C. (2017). Targeting MicroRNAs in cancer gene therapy. Genes 8, pii: E21. https://doi.org/10.3390/genes8010021
- Jikuzono, T., Kawamoto, M., Yoshitake, H., Kikuchi, K., Akasu, H., Ishikawa, H., Hirokawa, M., Miyauchi, A., Tsuchiya, S., Shimizu, K., et al. (2013). The miR-221/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma. Int. J. Oncol. 42, 1858-1868. https://doi.org/10.3892/ijo.2013.1879
- Lei, G.S., Kline, H.L., Lee, C.H., Wilkes, D.S., and Zhang, C. (2016). Regulation of collagen V expression and epithelial-mesenchymal transition by miR-185 and miR-186 during idiopathic pulmonary fibrosis. Am. J. Pathol. 186, 2310-2316. https://doi.org/10.1016/j.ajpath.2016.04.015
-
Liu, L., Wang, Y., Bai, R., Yang, K., and Tian, Z. (2016a). MiR-186 inhibited aerobic glycolysis in gastric cancer via HIF-1
${\alpha}$ regulation. Oncogenesis 5, e224. https://doi.org/10.1038/oncsis.2016.35 - Liu, Z., Zhang, G., Yu, W., Gao, N., and Peng, J. (2016b). miR-186 inhibits cell proliferation in multiple myeloma by repressing Jagged1. Biochem. Biophys. Res. Commun. 469, 692-697. https://doi.org/10.1016/j.bbrc.2015.11.136
- Profumo, V., and Gandellini, P. (2013). MicroRNAs: cobblestones on the road to cancer metastasis. Crit. Rev. Oncogenesis 18, 341-355. https://doi.org/10.1615/CritRevOncog.2013007182
- Ridley, A.J. (2015). Rho GTPase signalling in cell migration. Curr. Opin. Cell Bio. 36, 103-112. https://doi.org/10.1016/j.ceb.2015.08.005
- Sun, X.J., Liu, H., Zhang, P., Zhang, X.D., Jiang, Z.W., and Jiang, C.C. (2013). miR-10b promotes migration and invasion in nasopharyngeal carcinoma cells. Asian Pac. J. Cancer Prev. 14, 5533-5537. https://doi.org/10.7314/APJCP.2013.14.9.5533
- Terzuoli, E., Donnini, S., Finetti, F., Nesi, G., Villari, D., Hanaka, H., Radmark, O., Giachetti, A., and Ziche, M. (2016). Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer. Oncotarget 7, 44350-44364. https://doi.org/10.18632/oncotarget.10051
- Yao, Y., Zhang, X., Chen, H.P., Li, L., Xie, W., Lan, G., Zhao, Z.W., Zheng, X.L., Wang, Z.B., and Tang, C.K. (2016). MicroRNA-186 promotes macrophage lipid accumulation and secretion of proinflammatory cytokines by targeting cystathionine gamma-lyase in THP-1 macrophages. Atherosclerosis 250, 122-132. https://doi.org/10.1016/j.atherosclerosis.2016.04.030
- Yu, X., Zhang, X., Dhakal, I.B., Beggs, M., Kadlubar, S., and Luo, D. (2012). Induction of cell proliferation and survival genes by estradiolrepressed microRNAs in breast cancer cells. BMC Cancer 12, 29. https://doi.org/10.1186/1471-2407-12-29
- Zatulovskiy, E., Tyson, R., Bretschneider, T., and Kay, R.R. (2014). Bleb-driven chemotaxis of Dictyostelium cells. J. Cell Biol. 204, 1027-1044. https://doi.org/10.1083/jcb.201306147
피인용 문헌
- Suppression of Disheveled–Axin Domain Containing 1 (DIXDC1) by MicroRNA-186 Inhibits the Proliferation and Invasion of Retinoblastoma Cells vol.64, pp.2, 2018, https://doi.org/10.1007/s12031-017-1017-7
- MicroRNA in Lung Cancer Metastasis vol.11, pp.2, 2019, https://doi.org/10.3390/cancers11020265
- Bi-directional exosome-driven intercommunication between the hepatic niche and cancer cells vol.16, pp.1, 2017, https://doi.org/10.1186/s12943-017-0740-6
- miR-186, a serum microRNA, induces endothelial cell apoptosis by targeting SMAD6 in Kawasaki disease vol.41, pp.4, 2017, https://doi.org/10.3892/ijmm.2018.3397
- Regulating Cdc42 and Its Signaling Pathways in Cancer: Small Molecules and MicroRNA as New Treatment Candidates vol.23, pp.4, 2017, https://doi.org/10.3390/molecules23040787
- Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells vol.18, pp.None, 2018, https://doi.org/10.1186/s12885-018-4258-0
- miR‐186 inhibits proliferation, migration, and epithelial‐mesenchymal transition in breast cancer cells by targeting Twist1 vol.120, pp.6, 2017, https://doi.org/10.1002/jcb.28283
- MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p vol.11, pp.11, 2017, https://doi.org/10.18632/aging.102003
- miR‐186 modulates hepatocellular carcinoma cell proliferation and mobility via targeting MCRS1‐mediated Wnt/β‐catenin signaling vol.234, pp.12, 2017, https://doi.org/10.1002/jcp.28878
- miR‐942 promotes tumor migration, invasion, and angiogenesis by regulating EMT via BARX2 in non‐small‐cell lung cancer vol.234, pp.12, 2017, https://doi.org/10.1002/jcp.28928
- Clinical Value of Serum and Exhaled Breath Condensate miR-186 and IL-1β Levels in Non-Small Cell Lung Cancer vol.19, pp.None, 2020, https://doi.org/10.1177/1533033820947490
- The effect of lncRNA‐ARAP1‐AS2/ARAP1 on high glucose‐induced cytoskeleton rearrangement and epithelial–mesenchymal transition in human renal tubular epithelial cells vol.235, pp.7, 2020, https://doi.org/10.1002/jcp.29512
- MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway vol.29, pp.3, 2020, https://doi.org/10.3233/cbm-201685
- Regulators at Every Step—How microRNAs Drive Tumor Cell Invasiveness and Metastasis vol.12, pp.12, 2017, https://doi.org/10.3390/cancers12123709